
Peter D. Kwong
Articles
-
Apr 25, 2024 |
nature.com | Christine Nelson |Hong-Su Park |Cindy Luongo |Shirin Munir |Peter D. Kwong |Kennichi Dowdell | +3 more
AbstractImmunization via the respiratory route is predicted to increase the effectiveness of a SARS-CoV-2 vaccine. Here, we evaluate the immunogenicity and protective efficacy of one or two doses of a live-attenuated murine pneumonia virus vector expressing SARS-CoV-2 prefusion-stabilized spike protein (MPV/S-2P), delivered intranasally/intratracheally to male rhesus macaques.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →